| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |